JPRN-jRCT1080224015已完成Unknown
Special Drug Use-Results Survey of Parsabiv [hemodialysis-related secondary hyperparathyroidism]
ONO PHARMACEUTICAL CO.,LTD.0 个研究点目标入组 1,200 人开始时间: 2018年7月26日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with secondary hyperparathyroidism on hemodialysis for whom Parsabiv is newly administered
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A Study of TAK-660 in surgical procedures for people with hemophilia AHemophilia AJPRN-jRCT2031210173Contact for Clinical Trial Information17
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
招募中
Unknown
Special Drug Use-Results Survey (All-Case Surveillance) to Investigate Safety and Effectiveness in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Empaveli in the Post-Marketing Clinical Use in JapaParoxysmal nocturnal hemoglobinuriaJPRN-jRCT2031230275Shimmoto Naoki100
已完成
Unknown
Special Drug Use-Results Survey of OPDIVO (classical Hodgkin's lymphoma)classical Hodgkin's lymphomaJPRN-jRCT1080224013ONO PHARMACEUTICAL CO.,LTD.250
已完成
Unknown
Special Drug Use-Results Survey of OPDIVO (NSCLC)non-small cell lung cancerJPRN-jRCT1080223216ONO PHARMACEUTICAL CO., LTD.1,000